Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gottwik

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Heart Journal|October 18, 2006
Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practiceUwe Zeymer, Anselm K Gitt, Claus Jünger, et al.
The American Journal of Cardiology|February 28, 2002
Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry)Tobias Heer, Rudolf Schiele, Steffen Schneider, et al.
European Heart Journal|February 25, 2005
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?Herbert Lorenz, Claus Jünger, Karlheinz Seidl, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 7, 2013
Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA studySpyridon Liosis, Timm Bauer, Rudolf Schiele, et al.
Cardiovascular Drugs and Therapy|November 25, 2006
Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-studyBernhard Rauch, Rudolf Schiele, Steffen Schneider, et al.
The American Journal of Cardiology|January 2, 2013
Usefulness of heart rate to predict one-year mortality in patients with atrial fibrillation and acute myocardial infarction (from the OMEGA trial)Jin Li, Ruediger Becker, Bernhard Rauch, et al.
Circulation|March 12, 2003
Antibiotic therapy after acute myocardial infarction: a prospective randomized studyRalf Zahn, Steffen Schneider, Birgit Frilling, et al.
Circulation|November 10, 2010
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarctionBernhard Rauch, Rudolf Schiele, Steffen Schneider, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 15, 2009
In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backupUlrich Tebbe, Matthias Hochadel, Peter Bramlage, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Heart Journal|October 18, 2006
Effect of clopidogrel on 1-year mortality in hospital survivors of acute ST-segment elevation myocardial infarction in clinical practiceUwe Zeymer, Anselm K Gitt, Claus Jünger, et al.
The American Journal of Cardiology|February 28, 2002
Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry)Tobias Heer, Rudolf Schiele, Steffen Schneider, et al.
European Heart Journal|February 25, 2005
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction?Herbert Lorenz, Claus Jünger, Karlheinz Seidl, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 7, 2013
Predictors of 1-year mortality in patients with contemporary guideline-adherent therapy after acute myocardial infarction: results from the OMEGA studySpyridon Liosis, Timm Bauer, Rudolf Schiele, et al.
Cardiovascular Drugs and Therapy|November 25, 2006
Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-studyBernhard Rauch, Rudolf Schiele, Steffen Schneider, et al.
The American Journal of Cardiology|January 2, 2013
Usefulness of heart rate to predict one-year mortality in patients with atrial fibrillation and acute myocardial infarction (from the OMEGA trial)Jin Li, Ruediger Becker, Bernhard Rauch, et al.
Circulation|March 12, 2003
Antibiotic therapy after acute myocardial infarction: a prospective randomized studyRalf Zahn, Steffen Schneider, Birgit Frilling, et al.
Circulation|November 10, 2010
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarctionBernhard Rauch, Rudolf Schiele, Steffen Schneider, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 15, 2009
In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backupUlrich Tebbe, Matthias Hochadel, Peter Bramlage, et al.
JAMA|July 2, 2016
Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical TrialChristiane E Angermann, Götz Gelbrich, Stefan Störk, et al.
Pageof 2